Citigroup
KITE

Citigroup’s Kite Pharma, Inc. KITE Stock Holding History

Citigroup’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-356,484
Closed -$64.1M – 7796
2017
Q3 		$64.1M Buy
356,484
+295,533
+485% +$41.2M 0.05% 318
2017
Q2 		$6.32M Buy
60,951
+22,469
+58% +$1.83M 0.01% 1514
2017
Q1 		$3.02M Sell
38,482
-170,149
-82% -$10.5M ﹤0.01% 2089
2016
Q4 		$9.36M Buy
208,631
+190,451
+1,048% +$9.34M 0.01% 1245
2016
Q3 		$1.01M Buy
18,180
+7,865
+76% +$438K ﹤0.01% 3204
2016
Q2 		$516K Sell
10,315
-23,643
-70% -$1.16M ﹤0.01% 3630
2016
Q1 		$1.56M Buy
33,958
+21,391
+170% +$1.04M ﹤0.01% 2806
2015
Q4 		$775K Sell
12,567
-3,877
-24% -$273K ﹤0.01% 3411
2015
Q3 		$915K Sell
16,444
-1,951
-11% -$123K ﹤0.01% 3176
2015
Q2 		$1.12M Buy
18,395
+6,366
+53% +$363K ﹤0.01% 3068
2015
Q1 		$695K Buy
12,029
+368
+3% +$24.7K ﹤0.01% 3438
2014
Q4 		$673K Buy
11,661
+10,019
+610% +$422K ﹤0.01% 3569
2014
Q3 		$47K Buy
+1,642
New +$40.6K ﹤0.01% 5353

Citigroup's KITE Position: Q4 2017 in Review

Citigroup sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 356,484 shares — an estimated $64.1M sold.

Citigroup first reported a position in KITE in Q3 2014 and held it in 13 quarters. The position peaked at $64.1M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Citigroup reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Citigroup sold 356,484 Kite Pharma, Inc. shares in Q4 2017, an estimated $64.1M.
  • Citigroup first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 13 quarters.
  • Citigroup's Kite Pharma, Inc. position peaked at $64.1M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Citigroup's 13F filing for Q4 2017, filed 12 Feb 2018.